M&r Capital Management Inc buys $6,131,451 stake in Henry Schein (HSIC)

Henry Schein (HSIC) : M&r Capital Management Inc scooped up 18,007 additional shares in Henry Schein during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 10, 2016. The investment management firm now holds a total of 37,057 shares of Henry Schein which is valued at $6,131,451.Henry Schein makes up approximately 1.55% of M&r Capital Management Inc’s portfolio.

Other Hedge Funds, Including , Massmutual Trust Co Fsbadv reduced its stake in HSIC by selling 85 shares or 1.66% in the most recent quarter. The Hedge Fund company now holds 5,044 shares of HSIC which is valued at $834,580. Henry Schein makes up approx 0.10% of Massmutual Trust Co Fsbadv’s portfolio.10-15 Associates boosted its stake in HSIC in the latest quarter, The investment management firm added 446 additional shares and now holds a total of 6,329 shares of Henry Schein which is valued at $1,056,690. Henry Schein makes up approx 0.29% of 10-15 Associates’s portfolio.Checchi Capital Advisers reduced its stake in HSIC by selling 43 shares or 5.42% in the most recent quarter. The Hedge Fund company now holds 750 shares of HSIC which is valued at $135,495. Henry Schein makes up approx 0.03% of Checchi Capital Advisers’s portfolio. Regentatlantic Capital added HSIC to its portfolio by purchasing 5,564 company shares during the most recent quarter which is valued at $1,006,305. Henry Schein makes up approx 0.09% of Regentatlantic Capital’s portfolio.

Henry Schein closed down -0.1 points or -0.06% at $161.29 with 7,23,290 shares getting traded on Friday. Post opening the session at $161.2, the shares hit an intraday low of $159.58 and an intraday high of $161.42 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Henry Schein reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $1.63. The company had revenue of $2872.60 million for the quarter, compared to analysts expectations of $2845.09 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.

Leave a Reply

Henry Schein - Is it time to Sell?

Top Brokerage Firms are advising their investors on Henry Schein. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.